Diabetic Foot Ulcer Treatment Market Analysis

  • Report ID: 4603
  • Published Date: Mar 03, 2023
  • Report Format: PDF, PPT

Diabetic Foot Ulcer Treatment Market Analysis

Ulcer Type (Neuropathic Ulcer, Ischemic Ulcer, Neuro-Ischemic Ulcer)

The global diabetic foot ulcer treatment market is segmented and analyzed for demand and supply by ulcer type into a neuropathic ulcer, ischemic ulcer, and neuro-ischemic ulcer. Among these segments, the neuropathic ulcer segment is anticipated to capture the largest market size in the global diabetic foot ulcer treatment market owing to an increase in peripheral neuropathy cases among diabetics. It was observed that approximately 48% of diabetic patients experience peripheral neuropathy at some point in their lives, with prevalence ranging from 7% to 50% based on factors such as diabetes type and glycemic control. Furthermore, the number of risks associated with neuropathic ulcers, such as infection, amputation, and death, and increasing treatment options for ulcer diagnosis is projected to augment segment growth over the forecast period.

End-user (Hospitals, Clinics, Ambulatory Surgical Centers, Homecare)

The global diabetic foot ulcer treatment market is also segmented and analyzed for demand and supply by end-user into hospitals, clinics, ambulatory surgical centers, and homecare. Amongst these four segments, the hospital segment is expected to garner a significant share. The patient suffering with diabetic ulcers should be taken to hospitals, as ulcers can lead to severe infection and it can increase the risk of amputation. Therefore, to avoid the stage of amputation, the patient should be given immediate care of the hospital for dealing with complicated ulcers. The properly trained staff of the hospital can provide intensive care and the patient can be treated with multiple services present in the hospital.

Our in-depth analysis of the global market includes the following segments:

      By Ulcer Type

  • Neuropathic Ulcer
  • Ischemic Ulcer
  • Neuro-Ischemic Ulcer

       By Product

  • Wound-Care Dressings
  • Wound-Care Devices
  • Active Therapies
  • Others

         By End User

  • Hospitals
  • Clinics
  • Ambulatory Surgical Centers
  • Homecare
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 4603
  • Published Date: Mar 03, 2023
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

An increase in sedentary lifestyles, surge in number of people suffering from type 2 diabetes along with increasing obesity among people are the major factors driving the market growth.

The market is anticipated to attain a CAGR of 6% over the forecast period, i.e., 2023 - 2033.

High cost associated with advanced diabetic foot ulcer treatment and patient management rules and regulations are the challenges affecting the market growth.

The market in North America is projected to hold the largest market share by the end of 2033 and provide more business opportunities in the future.

The major players in the market are UPM, Orpyx Medical Technologies Inc., PENTAX Medical, Smith & Nephew plc, Organogenesis Inc., SIGVARIS GROUP, 3M, Molnlycke Health Care AB, Hill-Rom Holdings, Inc., ConvaTec Inc.

The company profiles are selected based on the revenues generated from the product segment, geographical presence of the company which determine the revenue generating capacity as well as the new products being launched into the market by the company.

The market is segmented by ulcer type, product, end user and, by region.

The neuropathic ulcer segment is anticipated to garner the largest market size by the end of 2033 and display significant growth opportunities.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying